Vimarsana.com

Latest Breaking News On - Laucoma - Page 4 : vimarsana.com

Glaucoma Therapeutics Market Size Projected to Reach USD 13.5 billion by 2031, With 5.5% CAGR: Transparency Market Research, Inc.

Pharmacological actions of several ophthalmic medications are directed against glaucoma. In order to treat glaucoma, a few more recent drug classes assist in increasing aqueous fluid outflow and lower intraocular pressure.Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global glaucoma therapeutics market was projected to attain US$ 8.3 billion in 2022. It is anticipated to garner a 5.5% CAGR from 2023 to 2031 and by 2031, the market

Delaware
United-states
Canada
China
America
Americans
Nikhil-alani
Asia-pacific
Aerie-pharmaceuticals
Alembic-pharmaceuticals
National-diabetes-statistics
Merck-co

Health Beat: Eyes, ears and dementia risk

There are more than 55 million people in the world living with dementia. As researchers try to learn more about how to identify this disease earlier, they’ve found that your

Cecilia-lee
American-optometric-association
University-of-washington-school-medicine
Washington-school
Dementia
Lzheimers-disease
Ognitive-disorders
Niversity-of-washington-school-medicine
Ecelia-lee
Iabetic-retinopathy
Laucoma

Photonic Technologies Introduce New Ways to Diagnose Menopause and Glaucoma

The Optica Foundation today released more detailed information on new women's health and vision research funded by the 2023 Optica Foundation Challenge. Researchers Samantha Grist, The University of British Columbia, Canada, and Fernando Zvietcovich, Pontificia Universidad Catolica del Peru, Peru, have proposed two separate light-based techniques to solve for challenges in diagnosing health-related concerns, specifically menopause and glaucoma.

Peru
United-kingdom
Canada
British
Canadian
Alan-willner
Pontificia-universidad-catolica
Fernando-zvietcovich
Selection-committee
Herstasis-health
Optica-foundation
World-bank

vimarsana © 2020. All Rights Reserved.